Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Biodistribution, toxicity of suicide gene adenovirus therapy studied in vivo

Feb. 17, 2009

Amgen scientists describe new Smo receptor antagonists in recent patent

Feb. 17, 2009

France approves named patient supply for Ark's Cerepro

Feb. 16, 2009

IDMC for phase III trial of motesanib recommends resumption of enrollment

Feb. 16, 2009

Oasmia's phase III Paclical study generates physician interest in Europe

Feb. 16, 2009

Novogen plans to focus activities on its oncology program

Feb. 16, 2009

NeoPharm submits application to FDA for phase II study of LE-DT in prostate cancer

Feb. 16, 2009

Astex and Cancer Research U.K. sign CTA for AT-9283 in childhood cancer

Feb. 16, 2009

Merck & Co. imparts novel HDAC inhibitors for treating cancer

Feb. 16, 2009

Novel Hsp90 inhibitors under development at Merck KGaA for the treatment of cancer

Feb. 16, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 16, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Anti-C5aR1 antibodies linked to outcomes in giant cell arteritis
BioWorld Science
More effective glucocorticoid-sparing therapies are needed for the treatment of giant cell arteritis (GCA). Studies found that complement signaling pathways...
Fortvita and Innovent patent new anti-TROP2/B7-H4 ADCs
BioWorld Science
Fortvita Biologics Inc. and Innovent Biologics (Suzhou) Co. Ltd. have jointly reported new antibody-drug conjugates (ADCs) comprising a bispecific antibody or...